MLKL and hematoma: In our study, serum MLKL levels had similar AUC to NIHSS scores and hematoma volume, signifying that serum MLKL may be clinically valuable in anticipation of END and poor prognosis in ICH, hopefully leading to improvement of patient outcomes or refinement of risk stratification methods.